← SynDRA
BALOXAVIR
SynDRA canonical compound SYN0039424 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Mechanism of action | endonuclease inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- endonuclease inhibitor
- Influ PA INHIBITOR
- PA INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ABCB11
- HTR2B
- SLC6A4
- SLC6A3
- SLC6A2
- SCN5A
- PTGS1
- PGR
- PDE4A
- PDE3A
- OPRM1
- MAOA
- KDR
- KCNH2
- HTR1A
- ACHE
- HRH3
- F2
- ESR1
- DRD3
- DRD1
- CHRM2
- CHRM1
- CACNA1C
- AR
- ADRA2A
- ADRA1A
- ADORA3
- TBXA2R
Drug classes
- Antiviral Agents
- Enzyme Inhibitors
- Anti-Infective Agents
ATC classes
- J05A · DIRECT ACTING ANTIVIRALS
Cross-references
Synonyms
- S-033447
- 4G86Y4JT3F
- RefChem:56254
- DTXCID001513438
- Baloxavir acid
- MFCD31619273
- Baloxavir (USAN)
- BALOXAVIR [USAN]
- C24H19F2N3O4S
- E4Z
- Baloxavir (Standard)
- BALOXAVIR [MI]
- Baloxavir(S-033447)
- UNII-4G86Y4JT3F
- orb1308587
- SCHEMBL20101933
- SCHEMBL29349549
- GLXC-20138
- EX-A2723
- HY-109025AR
- KED60559
- BDBM50612273
- AKOS040741288
- HY-109025A
- AC-31577
- AS-76483
- DA-61488
- SY288033
- CS-0039267
- D11278
- D97646
- T14495
- B011458
- F845040
- 巴洛沙韦
- SCHEMBL20924862
- Baloxavir Impurity 116
- HMS5087P07
Reported adverse events
- Anaphylactic reaction
- Rash
- Sinusitis
- Vomiting
- Bronchitis
- Delirium
- Headache
- Nausea
Look up BALOXAVIR in the interactive SynDRA portal →